Stay updated on Venetoclax and Novel Agents in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.

Latest updates to the Venetoclax and Novel Agents in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check20 days agoChange DetectedA notice announces that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and directs visitors to updates and FAQs.SummaryDifference0.5%

- Check27 days agoChange DetectedThe footer’s ClinicalTrials.gov software revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check34 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check41 days agoChange DetectedThe record now shows a study-status update submitted on September 30 and posted October 5, replacing the prior June 8 update date.SummaryDifference0.3%

- Check55 days agoChange DetectedAn added UI label 'Find contact information' appears in the history, and the revision note updates to v3.7.0. These changes are minor UI/text and versioning adjustments rather than substantive alterations to the study data or core content.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Novel Agents in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.